Predicted to enable L-threonine 3-dehydrogenase activity. Involved in innate immune response. Is an ortholog of human TDH (L-threonine dehydrogenase (pseudogene)).
Predicted to enable glutathione hydrolase activity. Predicted to be involved in glutathione catabolic process. Predicted to be located in plasma membrane. Human ortholog(s) of this gene implicated in several diseases, including biliary atresia; diabetes mellitus (multiple); and liver disease (multiple). Is an ortholog of human GGT1 (gamma-glutamyltransferase 1); GGT2P (gamma-glutamyltransferase 2, pseudogene); and GGT3P (gamma-glutamyltransferase 3 pseudogene).
Predicted to enable glutathione hydrolase activity. Predicted to be involved in glutathione catabolic process. Predicted to be located in plasma membrane. Human ortholog(s) of this gene implicated in several diseases, including biliary atresia; diabetes mellitus (multiple); and liver disease (multiple). Is an ortholog of human GGT1 (gamma-glutamyltransferase 1); GGT2P (gamma-glutamyltransferase 2, pseudogene); and GGT3P (gamma-glutamyltransferase 3 pseudogene).
Involved in transcription elongation by RNA polymerase II. Part of transcription elongation factor complex. Is an ortholog of human ELOA2 (elongin A2) and ELOA3DP (elongin A3 family member D, pseudogene).
Enriched in Z1 and Z4 based on RNA-seq studies. Is affected by several genes including daf-16; daf-2; and pgl-1 based on RNA-seq and microarray studies. Is affected by multi-walled carbon nanotube based on RNA-seq studies.